TB-500 Reconstitution Guide: Laboratory Preparation Protocol for Research
TB-500 Reconstitution Guide: Laboratory Preparation Protocol for Research
Thymosin Beta-4 (TB-500) represents a synthetic analog of the naturally occurring peptide thymosin β4, featuring a 43-amino acid sequence that plays crucial roles in cellular migration, proliferation, and tissue repair mechanisms. This lyophilized research compound requires precise reconstitution protocols to maintain structural integrity and biological activity for in vitro experimental applications. Laboratory researchers utilize TB-500 in studies examining wound healing pathways, angiogenesis processes, and cellular regeneration mechanisms.
Required Laboratory Materials
TB-500 5mg lyophilized vial (Element SARMs)
Bacteriostatic water for injection (BWFI) or sterile water for injection
1mL sterile syringes with 27-30 gauge needles
Alcohol swabs (70% isopropanol)
Laminar flow hood or biosafety cabinet
Sterile vial caps or parafilm
Laboratory marker for labeling
Refrigeration unit maintaining 2-8°C
Vortex mixer (optional, low speed only)
Pre-Reconstitution Laboratory Preparation
Establish aseptic conditions within a laminar flow hood to prevent contamination during the reconstitution process. Allow the lyophilized TB-500 vial to reach room temperature for approximately 15-20 minutes before beginning the procedure. This temperature equilibration prevents thermal shock that could potentially denature the peptide structure. Inspect the lyophilized powder for any discoloration or unusual appearance; properly stored TB-500 should appear as a white to off-white powder.
Prepare the reconstitution solvent by selecting either bacteriostatic water containing 0.9% benzyl alcohol or sterile water for injection. Bacteriostatic water provides extended storage stability for multi-use applications, while sterile water offers optimal compatibility for immediate single-use experiments. Calculate the required solvent volume based on desired final concentration requirements for your specific research protocol.
Solvent Selection Considerations
Research applications requiring immediate use benefit from sterile water reconstitution, as this eliminates any potential interference from preservatives. Long-term storage scenarios favor bacteriostatic water due to its antimicrobial properties that maintain solution stability over extended periods. Consider the experimental timeline and storage requirements when selecting the appropriate reconstitution medium.
Step-by-Step Reconstitution Protocol
Step 1: Remove the protective cap from the TB-500 vial and clean the rubber stopper thoroughly with 70% isopropanol swabs. Allow complete evaporation of the alcohol before proceeding.
Step 2: Draw the calculated volume of reconstitution solvent into a sterile syringe, ensuring no air bubbles remain within the syringe barrel.
Step 3: Insert the needle through the rubber stopper at a slight angle to prevent coring. Direct the needle toward the vial wall rather than directly onto the lyophilized powder.
Step 4: Inject the solvent slowly along the vial wall, allowing it to gently flow down and contact the powder without creating excessive turbulence or foam formation.
Step 5: Remove the syringe and needle, then gently swirl the vial in circular motions to facilitate dissolution. Avoid vigorous shaking or vortexing at high speeds, which may damage the peptide structure.
Step 6: Allow the solution to stand for 5-10 minutes if complete dissolution has not occurred immediately. Gentle warming to room temperature may accelerate the dissolution process if necessary.
Final Concentration Calculations
The reconstituted TB-500 concentration depends on the solvent volume added to the 5mg lyophilized powder:
1.0 mL
5.0 mg/mL
0.2 mL
2.0 mL
2.5 mg/mL
0.4 mL
2.5 mL
2.0 mg/mL
0.5 mL
Storage Conditions and Stability
Store reconstituted TB-500 solutions at 2-8°C in a standard laboratory refrigerator. Solutions prepared with bacteriostatic water maintain stability for up to 30 days under proper refrigeration conditions. Sterile water preparations should be utilized within 72 hours to ensure optimal peptide integrity. Protect solutions from direct light exposure by wrapping vials in aluminum foil or storing in opaque containers.
Avoid repeated freeze-thaw cycles, which can cause peptide degradation and loss of biological activity. Aliquot larger volumes into smaller portions for single-use applications when conducting multiple experiments over time.
Research Application Notes
Element SARMs TB-500 demonstrates excellent solubility in aqueous solutions and maintains structural stability under proper storage conditions. Research applications typically involve cell culture studies examining migration patterns, wound healing assays, and angiogenesis models. The reconstituted peptide solution integrates seamlessly with standard laboratory cell culture media and experimental buffers.
Consider the experimental pH requirements when planning TB-500 applications, as the peptide maintains optimal stability within physiological pH ranges. Document reconstitution dates, concentrations, and storage conditions for proper laboratory record-keeping and experimental reproducibility.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Hexarelin
TB-500
Epithalon
Ipamorelin
Tirzepatide
CJC-1295 DAC
PT-141
Semaglutide
Selank
BPC-157
Sermorelin
Melanotan 2
IGF LR3
Tesamorelin
AICAR
IGF-DES
GHRP 2
Albuterol
Tamoxifen
Letrozole
Clomiphene
Tadalafil
Clenbuterol
Anastrozole
Finasteride
Exemestane
Sildenafil
Yohimbine
Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows
Already a customer? Sign In
Create Account
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
Sarms
Stacks
Research Liquids
Albuterol 5MG/ML | 30ML with dropper
Anastrozole 1.5MG/ML | 30ML with dropper
Clomiphene 50MG/ML | 30ML with dropper
Finasteride 5MG/ML | 30ML with dropper
Letrozole 3.5 MG/ML | 30ML with dropper
LiquiCia 30MG/ML | 30ML with dropper
LiquiCia T50 50MG/ML | 30ML with dropper
LiquiClen 200MCG/ML | 30ML with dropper
Liquistane / Exemestane 25MG/ML | 30ML with dropper
LiquiTamo 20MG/ML | 30ML with dropper
LiquiVia 25MG/ML | 30 ML with dropper
T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper
Toremifene Citrate 60MG/ML | 30ML with dropper
Yohimbine HCL 10MG/ML | 30ML with dropper
Research Peptides
Aicar 50MG
BPC-157 + TB-500 Blend 2mg ea/ 4MG
BPC-157 5MG
CJC-1295 + DAC 2MG
CJC-1295 | No DAC 2MG
Epithalon 10MG
Frag Premium 176-191 5MG
GHK-CU Copper Peptide 50MG
GHRP-2 5MG
GHRP-6 5MG
Hexarelin 5MG
IGF-1 DES 1MG
IGF-1 LR3 1MG
Ipamorelin 5MG
Melanotan 2 10MG
NAD+ 500MG
PT-141 / Bremelanotide 10MG
GLP-1/GIP/GCG (RT)
Selank 5MG
GLP1 (SM)
Sermorelin 5MG
TB-500 5MG
GIP/GLP-1 (TZ)
PDE5 Inhibitors
GLP-1
Diluents
Bacteriostatic Water 10ML